Cargando…
The Rise of SARS-CoV-2 (COVID-19) Omicron Subvariant Pathogenicity
During the COVID-19 pandemic, variants of the Betacoronavirus SARS-CoV-2, the etiologic agent of COVID-19 disease, progressively decreased in pathogenicity up to the Omicron strain. However, the case fatality rate has increased from Omicron through each major Omicron subvariant (BA.2/BA.4, BA.5, XBB...
Autores principales: | DeGrasse, David C, Black, Shaun D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260278/ https://www.ncbi.nlm.nih.gov/pubmed/37313287 http://dx.doi.org/10.7759/cureus.40148 |
Ejemplares similares
-
Correction: The Rise of SARS-CoV-2 (COVID-19) Omicron Subvariant Pathogenicity
por: DeGrasse, David C, et al.
Publicado: (2023) -
Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant Variant
por: Karyakarte, Rajesh P, et al.
Publicado: (2023) -
A Case Series of SARS-CoV-2 Omicron Variant in Patients With Acute Leukemia
por: Ali, Elrazi A, et al.
Publicado: (2022) -
An Early and Preliminary Assessment of the Clinical Severity of the Emerging SARS-CoV-2 Omicron Variants in Maharashtra, India
por: Karyakarte, Rajesh P, et al.
Publicado: (2022) -
Paediatric admissions with SARS-CoV-2 during the Delta and Omicron waves: an Australian single-centre retrospective study
por: Cheng, Daryl R, et al.
Publicado: (2023)